Afterward, after examining microarray data in the GENT2 database using the HG-U1333_Plus_2 platform, we found that CRBN mRNA expression was significantly downregulated in some cancer types such as brain, breast, colon, head and neck, kidney, lung, pancreas, skin, thyroid, and tongue (Figure 1b). This evidence concerns the gene CRBN and cancer.